Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.270
-0.020 (-0.61%)
May 1, 2026, 4:00 PM EDT - Market closed
Sana Biotechnology Market Cap
Sana Biotechnology has a market cap or net worth of $882.87 million as of May 1, 2026. Its market cap has increased by 148.32% in one year.
Market Cap
882.87M
Enterprise Value
830.75M
1-Year Change
148.32%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since the IPO on February 4, 2021, Sana Biotechnology's market cap has decreased from $1.33B to $882.87M, a decrease of -33.37%. That is a compound annual growth rate of -7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 882.87M | -18.56% |
| Dec 31, 2025 | 1.08B | 197.89% |
| Dec 31, 2024 | 363.93M | -54.75% |
| Dec 29, 2023 | 804.30M | 7.21% |
| Dec 30, 2022 | 750.19M | -73.52% |
| Dec 31, 2021 | 2.83B | 113.84% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytomX Therapeutics | 909.96M |
| SELLAS Life Sciences Group | 909.75M |
| LB Pharmaceuticals | 901.28M |
| Evommune | 882.45M |
| MannKind | 876.98M |
| Alto Neuroscience | 874.22M |
| Janux Therapeutics | 872.33M |
| MeiraGTx Holdings | 870.96M |